AMANTA
Amanta
Live Price
₹163.30
-0.26-0.16%
Conviction Scorecard
AI Momentum
43%Technical Rating
42%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for AMANTA will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Balanced market signals for AMANTA. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Amanta
Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.
Frequently asked questions
As of the latest market session, Amanta (AMANTA) is trading at ₹163.3, representing a move of -0.16% from the previous close.
Amanta is listed and traded under the ticker symbol AMANTA on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Amanta's stock price moved by -0.16%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 43% bullish probability for AMANTA stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Amanta shares reached a high of ₹209.95 and hit a low of ₹92.
AMANTA exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 1,27,429 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Amanta has a market capitalization of ₹634.08 Cr, designating its size class inside the Healthcare sector.
Amanta has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Amanta's trailing Price-to-Earnings (P/E) ratio is 39.25. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Amanta (AMANTA) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Amanta's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore AMANTA's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for AMANTA are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Amanta operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.